These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 19300116)

  • 1. Interesting findings in the VALERIA trial.
    Rosa EM; Viecceli C
    J Hypertens; 2009 Apr; 27(4):902; author reply 902-3. PubMed ID: 19300116
    [No Abstract]   [Full Text] [Related]  

  • 2. Valsartan in combination with lisinopril versus the respective high dose monotherapies in hypertensive patients with microalbuminuria: the VALERIA trial.
    Menne J; Farsang C; Deák L; Klebs S; Meier M; Handrock R; Sieder C; Haller H
    J Hypertens; 2008 Sep; 26(9):1860-7. PubMed ID: 18698222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination treatment effective option for hypertensive, diabetic patients with microalbuminuria.
    Chen BH
    CMAJ; 2001 Mar; 164(6):861. PubMed ID: 11276560
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination.
    Vivencio B
    Curr Med Res Opin; 2009 Sep; 25(9):2267-8; author reply 2268-9. PubMed ID: 19630488
    [No Abstract]   [Full Text] [Related]  

  • 5. [High dose sartan plus thiazide. Power duo in hypertension].
    MMW Fortschr Med; 2003 Feb; 145(6):60. PubMed ID: 12619369
    [No Abstract]   [Full Text] [Related]  

  • 6. [Valsartan: arguments for the high dose concept].
    MMW Fortschr Med; 2006 Dec; 148(51-52):54-5. PubMed ID: 17619348
    [No Abstract]   [Full Text] [Related]  

  • 7. [AT1-blocker in heart failure. Patients are readmitted more infrequently to the clinic].
    MMW Fortschr Med; 2000 Nov; 142(48):4-5. PubMed ID: 11144939
    [No Abstract]   [Full Text] [Related]  

  • 8. Japan. Tampered data cast shadow on drug trial.
    Normile D
    Science; 2013 Jul; 341(6143):223. PubMed ID: 23868992
    [No Abstract]   [Full Text] [Related]  

  • 9. Changing concepts in the management of hypertension: the role of effective and prompt blood pressure reduction.
    Berbari AE; Khayat A; Daouk N; Daouk M
    J Med Liban; 2008; 56(4):226-9. PubMed ID: 19115597
    [No Abstract]   [Full Text] [Related]  

  • 10. [Creatively revised quotation on sale arguments concerning Diovan (valsartan].
    Andersen SE; Pedersen ST
    Ugeskr Laeger; 2000 Nov; 162(47):6430. PubMed ID: 11116460
    [No Abstract]   [Full Text] [Related]  

  • 11. Can changing antihypertensive administration time alone reduce the risk for CVD in nondipper patients with CKD?
    Fukuda M
    Am J Kidney Dis; 2008 Jul; 52(1):193; author reply 193-4. PubMed ID: 18589219
    [No Abstract]   [Full Text] [Related]  

  • 12. AMAZE study--less than amazing results.
    Engelman K
    J Clin Hypertens (Greenwich); 2005 Sep; 7(9):565-6; author reply 566-8. PubMed ID: 16320445
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blinded trial evaluation of valsartan/hydrochlorothiazide combination therapy in mild to moderate essential hypertension in north-east China.
    Mualin I
    J Int Med Res; 2009; 37(1):277. PubMed ID: 19215702
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypertension: Benefits of combined therapy.
    Lim GB
    Nat Rev Cardiol; 2014 Aug; 11(8):435. PubMed ID: 24934875
    [No Abstract]   [Full Text] [Related]  

  • 16. Biomedicine. Faulty drug trials tarnish Japan's clinical research.
    Normile D
    Science; 2014 Jul; 345(6192):17. PubMed ID: 24994629
    [No Abstract]   [Full Text] [Related]  

  • 17. Valsartan/hydrochlorothiazide: pharmacology and clinical efficacy.
    Kondrack R; Mohiuddin S
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1125-34. PubMed ID: 19689218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prazosin in the treatment of resistant arterial hypertension associated with nephropathy].
    Cuesta V; Cannata J; Herrera J; Maisueche I; Peral V; Redondo C
    Rev Clin Esp; 1981 Apr; 161(1):37-9. PubMed ID: 7255814
    [No Abstract]   [Full Text] [Related]  

  • 20. Single-pill combination of amlodipine and valsartan in the management of hypertension.
    Flack JM; Hilkert R
    Expert Opin Pharmacother; 2009 Aug; 10(12):1979-94. PubMed ID: 19606937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.